Related Experiment Video
Updated: May 26, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Diabetic macular edema: new trends in management
Hanan Al Shamsi1, Nicola G Ghazi
1Vitroretinal Division, King Khaled Eye Specialist Hospital, PO Box 7191, Riyadh 11462, Saudi Arabia.
Diabetic macular edema treatment is shifting towards pharmacotherapy, with new agents showing greater efficacy than traditional laser therapy. Further research is needed to optimize treatment strategies for this condition.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacotherapy
Background:
- Diabetic macular edema treatment is transitioning from laser therapy to pharmacotherapy.
- Significant advancements in retinal pharmacotherapy have occurred over the past decade.
Purpose of the Study:
- To review new developments in diabetic macular edema treatment.
- To discuss emerging pharmacotherapeutic agents and modalities.
Main Methods:
- Review of current literature on diabetic macular edema treatments.
- Analysis of clinical trial data for novel pharmacotherapies.
Main Results:
- Several pharmacotherapies, including intravitreal injections and sustained delivery devices, are in clinical trials.
- Some new agents demonstrate superior efficacy compared to traditional laser therapy.
Conclusions:
- Pharmacotherapy represents a promising evolution in treating diabetic macular edema.
- Further research is essential to establish optimal treatment regimens and combinations.
Related Concept Videos
Diabetic Retinopathy
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Glaucoma: Overview
Nephrotic Syndrome II : Assessment and Medical Management